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Abstract
Background: Oxidative stress has shown to contribute in the mechanisms underlying apoptotic
cell death occuring in AIDS-dementia complex. Here we investigated the role of peroxynitrite in
apoptosis occurring in astroglial cells incubated with supernatants of HIV-infected human primary
macrophages (M/M).
Results: Flow cytometric analysis (FACS) of human cultured astrocytes shortly incubated with
HIV-1-infected M/M supernatants showed apoptotic cell death, an effect accompanied by
pronounced staining for nitrotyrosine (footprint of peroxynitrite) and by abnormal formation of
malondialdehyde (MDA). Pretreatment of astrocytes with the peroxynitrite decomposition catalyst
FeTMPS antagonized HIV-related astrocytic apoptosis, MDA formation and nitrotyrosine staining.
Conclusions:  Taken together, our results suggest that inibition of peroxynitrite leads to
protection against peroxidative stress accompanying HIV-related apoptosis of astrocytes. Overall
results support the role of peroxynitrite in HIV-related programmed death of astrocytes and
suggest the use of peroxynitrite decomposition catalyst to counteract HIV-1-related neurological
disorders.
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Background
Evidence exists suggesting that HIV-1-infected patients are
under chronic oxidative stress [1,2]. Major causes of the
increased concentration of free radicals are: i) a depletion
of protective systems (glutathione peroxidase, superoxide
dismutase, vitamin E, selenium), and an increased pro-
duction of free radicals (superoxide anion, hydroxyl radi-
cal) associated with the activation of lymphocytes and M/
M; ii) chronic inflammation; iii) increased polyunsaturat-
ed fatty acid concentration and lipid peroxidation; iv) the
direct or indirect effects of several opportunistic patho-
gens [1,3]. In addition, elevated serum levels of hydroper-
oxides and malondialdehyde, which are both indicative
of oxidative stress, have also been found in asymptomatic
HIV-1-infected patients early in the course of the disease
[2]. Despite the demonstrated role of free radicals in
AIDS-dementia complex, the mechanism underlying HIV-
related oxidative damage of CNS cells is still unknown.
Recently, it has been shown that astroglial apoptosis play
a key role in the neurological progression of HIV-1 associ-
ated dementia [4] and furthermore, incubation of astro-
glial cells with supernatants of HIV-infected macrophages
leads to astrocytic oxidative stress and then to apoptotic
cell death. This effect is attenuated by novel non peptidic
superoxide dismutase mimetics, thus supporting that an
abnormal generation of superoxide anions may contrib-
ute in HIV-related apoptosis [2,3]. Evidence exists that
HIV infetion is accompanied by simultaneous activation
of free radical species in CNS cells other then superoxide
anions, such as nitric oxide (NO). Since NO is able to
combine with superoxide anions to generate peroxyni-
trite, a nitrogen free radical [5] accounted to produce rele-
vant peroxidative HIV-related damage in CNS cells, it is
likely that abnormal release of peroxynitrite may play a
role in the apoptotic cell death which occurs when incu-
bating astroglial cells with supernatants of HIV-infected
M/M [6]. The present experiments have been performed
in order to evaluate the role of peroxynitrite in the apop-
totic cell death of astroglial cells incubated with superna-
tants of HIV-1-infected M/M and ascertain the protective
effect of FeTMPS, a novel peroxynitrite decomposition
catalyst on HIV-1-related apoptosis of astroglial cells.
Results
Effect of HIV-1 infected macrophage supernatant on as-
troglial cells
Time-course studies revealed that astroglial cell apoptosis
occurred between 6 and 8 days after addition of the super-
natant from HIV-1 infected macrophages. Thus results
will be shown at day 8. In particular, when astrocytes were
incubated with supernatants of HIV-infected M/M, a dra-
matic reduction of cell viability was seen at day 8 by flow
cytometric analysis (FACS). In sharp contrast, superna-
tants of mock-infected M/M only marginally affected as-
trocytes viability. The cytopathic effect observed in
astrocytes exposed to HIV-1-infected M/M supernatants
was mainly related to apoptosis. Indeed, FACS analysis
showed apoptosis in 49% and 7% of astrocytes exposed to
HIV-1-infected M/M or mock-infected cells, respectively
(Fig. 1). Indeed, 121 nmol of MDA/mg protein of cell ho-
mogenate were found in astroglial cells at day 8 after ex-
posure to HIV-1-infected M/M supernatants, with an
increment of MDA production of about 9-fold compared
to controls (Fig. 2). Neither apoptotic phenomena, nor
MDA over production were generated after incubation of
astroglial cells with supernatants from mock-infected M/
M (Fig. 1 and 2).
When cells were treated with supernatants of HIV-1-in-
fected M/M, a corresponding increase in the number of
cells that stained with nitrotyrosine-specific mouse anti-
serum was observed at day 2 (Fig. 3), indicating that an
HIV-related peroxynitrite formation occurred in astroglial
cells. No apoptosis was seen at day 2.
Effect of FeTMPS on astroglial cells following incubation 
with supernatants from HIV-1 infected macrophages
Dose responses with FeTMPS were performed (1–30 M)
and maximal effects were obtained between 10 and 30
M. Results at the highest dose used are shown. Pretreat-
ment of astrocytes with peroxynitrite decomposition cata-
lyst FeTMPS strongly antagonized apoptosis induced by
HIV-1-infected M/M supernatants. FeTMPS showed a po-
tent dose-dependent effect as assesed by FACS analysis at
day 8, only 10% of astroglial cells exposed to supernatants
from HIV-1-infected M/M, and treated with 30 M
FeTMPS, showed signs of apoptosis, compared to 49% of
untreated astrocytes similarly exposed to HIV-1-infected
M/M supernatants (Fig. 1). In addition, MDA overproduc-
tion was significantly decreased by FeTMPS: 121 and 38
nmol MDA/mg protein of cell homogenate were meas-
ured in not-treated and FeTMPS-treated astroglial cell cul-
tures respectively, at day 8 after the exposure to HIV-1-
infected M/M supernatants (Fig. 2). In sharp contrast,
treatment of astrocytes with H2TMPS (an inactive ana-
logue compound of FeTMPS; 30 M), or FeCl3 (30 M)
failed to prevent both apoptosis and MDA formation (Fig.
1 and 2). On the other hand, nitrotyrosine staining was
decreased using the active catalyst FeTMPS (Fig. 3).
FeTMPS did not affect, when incubated in the absence of
M/M supernatants, viability of astroglial cells at concen-
tration up to 50 M (data not shown).
Discussion
The alteration of the homeostasis induced by HIV-1 infec-
tion, with consequent production of toxic factors, is
claimed to be the main cause of neuronal damage during
AIDS. In particular, the release of some coating compo-
nent of HIV-1, such as gp120 glycoprotein or Tat, by HIV-
1-infected M/M produces both direct and indirect effectsBMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/13
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Figure 1
FeTMPS prevents apoptosis in astroglial cells induced by HIV-1-infected M/M. Supernatants from HIV-1 infected M/M (M/M +
HIV) produces apoptotic cell death of astroglial cells (c) greater than supernatants from mock-infected (M/M) (b) as evaluated
by FACS analysis 8 days after exposure to supernatants. FeTMPS (d), but not H2TMPS (e) or FeCl3 (f), antagonized this effect.BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/13
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in the central nervous system (CNS) [7–9]. Indeed, gp120,
Tat and TNF are capable to produce apoptotic cell death
via cytokine release or caspase activation [10–13]. In vitro
incubation of glial cells and neurons with gp120 or Tat
leads to release of large amount of free radicals and, in
turn, to neurodegenerative effects by activation of both cy-
tokine network and excitatory amino acid NMDA receptor
sensitization [14–17].
Previous studies have shown that HIV-1-infected M/M are
able to induce apoptosis of T-lymphocytes or astroglial
cells via overproduction of several factors, including pros-
taglandins, CD95-ligand, and free-radicals [18,19]. Fur-
thermore, arachidonic acid produced by infected M/M has
been reported able to cause neuronal damage [14]. Final-
ly, it has been shown that HIV-1 infection induces a heavy
perturbation of oxidative status of M/M, including in-
creased production of MDA, and decreased synthesis of
endogenous glutathione [20] thus indicating that the in-
teraction of HIV-1 with macrophages/microglial cells and
the release of HIV-1 components into CNS represents ap-
optotic cell death of brain cells in neuroAIDS, via ROS
overproduction. This is also shown by our experiments
where we found that the HIV-supernatants-mediated ap-
Figure 2
Malondialdehyde increases within astroglial cells incubated with supernatants of HIV-infected M/M (M/M + HIV) but not after
exposure to supernatants from mock-infected M/M (M/M). FeTMPS antagonized MDA overproduction, while H2TMPS or
FeCl3 failed to antagonize lipid peroxydation. Values are the mean out of four independent experiments. Error bars represent
standard deviations. * P < 0.05 FeTMPS-treated vs FeTMPS-untreated astroglial cellsBMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/13
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Figure 3
Nitrotyrosine staining in astroglial cells either untreated (a) or pre-treated with supernatants of HIV-1-infected macrophages
(b,c,d). In particular, the supernatant of HIV-infected macrophages enhanced the immunocytochemical expression of nitrotyro-
sine (b), indicating an increased production of peroxynitrite. Incubation of cells with FeTMPS (c) but not with the inactive cata-
lyst H2TMPS (d) inhibited HIV-related peroxynitrite formation in astrocytes. These are representative photomicrographs
(optical microscopy 40) out of four independent experiments.BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/13
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optosis of astroglial cells was accompanied by an in-
creased generation of free radicals, in particular of
peroxynitrite, the reaction product of nitric oxide and su-
peroxide [5]. The role of peroxynitrite in our study was as-
sessed by the use of the peroxynitrite decomposition
catalyst, FeTMPS which catalytically decompose peroxyni-
trite to nitrate [21,22]. In previous studies, FeTMPS but
not H2TMPS (inactive analog) [21] was found to be pro-
tective against peroxynitrite-mediated damage in vitro as
well as in several animals models of acute and chronic in-
flammation [23–26]. Importantly, FeTMPS does not in-
teract with NO making it an important tool to assess
peroxynitrite-mediated damage [23–25].
Our results suggest that overproduction of peroxynitrite,
possibly via the release of pro-inflammatory substances
by HIV infected macrophages/microglial cells, may con-
tribute in the pathophysiological mechanisms underlying
astroglial apoptotic cell death in neuro-AIDS. In addition,
due to their innovative pharmacological profile, the use of
novel non peptidyl peroxynitrite decomposition catalyst,
such as FeTMPS, may represent the basis for alternative
and efficient strategies in the treatment of neuroAIDS.
Methods
Cell cultures
Human primary macrophages
Peripheral blood mononuclear cells (PBMCs) were ob-
tained from the blood of healthy seronegative donors by
separation over Ficoll-Hypaque gradient. After separation,
PBMCs were seeded at a density of 6  106 cells/ml in 25
cm2 plastic flasks in RPMI 1640 with the addition of 50 U/
ml penicillin, 50 g/ml streptomycin, 2 mM L-glutamine,
and 20% heat-inactivated, mycoplasma- and endotoxin-
free fetal calf serum (FCS) (hereinafter called complete
medium). Cells were incubated at 37C in humidified air
containing 5% CO2. After 5 days of culture, non-adherent
cells were removed by repeated washing with warm medi-
um. Macrophages obtained with this method resulted in
>95% of purity analyzed by flow cytometry analysis.
Human astrocytoma cell line
The astroglial cell line Lipari was derived from a 51-year
old male patient who presented a large right front-tempo-
ral mass (astrocytoma) [27], these cells are not permissive
to HIV-1 infection [28]. Cells were expanded and cultured
by seeding them in 25 cm2 plastic flasks at a density of 0.7
 106 cells/flask in complete medium, and incubated at
37C in humidified air containing 5% CO2.
HIV-1 strain and M/M infection
A monocytotropic strain of HIV-1, named HIV-1Ba-L, was
used in all experiments. Characteristics and genomic se-
quence of this strain have been previously described
[29,30]. The virus was expanded in M/M, collected, fil-
tered and stored at -80C before use. Its concentration was
2.1  108 genomes, corresponding to 35 ng of p24 gag an-
tigen (Ag), and 5,000 tissue culture infectious doses 50%
per ml (TCID50/ml) as assessed by virus titration in M/M.
Macrophages were challenged for 2 hours with 300
TCID50/ml of virus, then extensively washed with warm
medium to remove the excess of virus, and finally cultured
in complete medium at the same conditions as before.
Macrophages were washed and fed every 7 days with fresh
complete medium. Supernatants of HIV-1-infected and
mock-infected M/M were collected at day 14 after virus
challenge, spun to remove cells and cellular debris, and
stored at -80C until use. Virus production was deter-
mined by the antigen-capture assay using a commercially
available p24 gag Ag kit (Abbott Pomezia, Italy).
Challenge of astrocytes
Astrocytes were incubated with supernatants from HIV-1-
infected M/M or mock-infected M/M for 4 hours at 37C
in humidified incubator. FeTMPS (30 M), H2TMPS (30
M) or FeCl3 (30 M) were added immediately before ex-
posure to supernatants of HIV-1-infected or mock-infect-
ed M/M. Four hours later, cells were carefully and
repeatedly washed (at least 5 times) to remove M/M su-
pernatants, and cultured in complete medium with and
without a daily treatment with all the compounds used in
this study for the duration of the experiment (6–8 days).
Flow cytometric analysis (FACS)
Astrocytes treated or not treated with supernatants of HIV-
infected or mock-infected M/M were gently detached from
plastic 6–8 days after virus challenge. Aliquots of 5  105
cells were centrifuged at 300  g for 5 min; pellets were
washed with PBS, placed on ice, and overlaid with 0.5 ml
of a hypotonic fluorochrome solution containing 50 g/
ml propidium iodide, 0.1% sodium citrate, and 0.1% Tri-
ton X-100. After gentle resuspension in this solution, as-
trocytes were left at 4C for 30 min, in the absence of light,
before analysis. Propidium iodide-stained cells were ana-
lyzed with a FACScan Flow Cytometer (Becton Dickin-
son), fluorescence was measured between 565 and 605
nm. The data were acquired and analysed by the Lysis II
program.
Malondialdeyde (MDA) determinations
MDA has been used as a biochemical marker for lipid per-
oxidation and was measured by a method previously de-
scribed [31]. In particular, levels of MDA were measured
in astroglial cell homogenates 8 days after cell exposure to
supernatants of HIV-infected M/M as indicated above. In
particular, astroglial cells were frozen in liquid nitrogen,
and homogenized in potassium chloride (1.15%). Chlo-
roform (2 ml) was then added to each homogenate and
then spun for 30 min. The organic layer of the sample was
removed and dried under nitrogen gas and reconstitutedBMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/13
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with 100 l of saline. MDA generation was evaluated by
the assay of thiobarbituric acid (TBA)-reacting com-
pounds. In particular, the addition of a solution of 20 l
of sodium dodecyl sulphate (SDS; 8.1%), 150 l of 20%
acetic acid solution (pH3.5), 150 l of 0.8% TBA and 400
l of distilled water, produced a chromogenic product
which was extracted in n-butanol and pyridine. The or-
ganic layer was removed and MDA was read at 532 nm
and expressed as nmol MDA/mg protein of cell homoge-
nate.
Immunocytochemical Staining
Immunocytochemical staining for nitrotyrosine was per-
formed on treated or not treated astrocytes. Astrocytes
were fixed with 4% paraformaldeyde dissolved in 0.1%
phosphate buffer (pH 7.4). Nonspecific staining was
blocked with 3% normal goat serum in 0.5 M Tris-HCl,
pH 7.4 containing 0.2% Tween 20 for 1 h at room temper-
ature. All subsequent incubations were carried out in this
buffer. For detection of nitrotyrosine immunoreactivity,
cells were incubated for 16 h at 4C with an anti-nitroty-
rosine monoclonal Ab (Cayman, 1:500) at 4C. The pri-
mary Ab was then removed, and the cells were exposed to
the secondary Ab, which was a biotinylated goat anti-
mouse Ig (IgG), and avidin-biotin-horseradish peroxidase
(VECTASTAIN Elite ABC Kit; Vector Laboratories), fol-
lowed by diaminobenzedine.
Statistical analysis
Statistical significance and standards deviations were as-
sessed using the Student t test.
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